Lonza Rockland

About

Lonza Rockland represents a premier healthcare manufacturing facility operated by one of the world's leading contract development and manufacturing organizations. Located in Rockland, Maine, this specialized facility serves as part of Lonza's extensive global network spanning five continents with over 19,000 dedicated professionals. As an integrated CDMO, Lonza Rockland delivers comprehensive pharmaceutical and biotechnology manufacturing solutions across multiple therapeutic modalities. The facility specializes in advanced pharmaceutical manufacturing services including biologics development, small molecule APIs, and specialized drug product manufacturing. Lonza's integrated approach encompasses the complete development lifecycle from early-stage clinical trials through commercial production, supporting over 660 preclinical and clinical large molecules with a proven track record of bringing more than 450 molecules to market. Lonza Rockland leverages cutting-edge manufacturing technologies and maintains stringent quality standards essential for pharmaceutical production. The facility operates under rigorous regulatory compliance frameworks, supporting both established and emerging therapeutic modalities including mammalian biologics, highly potent APIs, and bioconjugates. Their comprehensive service portfolio includes process development, analytical testing, regulatory support, and commercial-scale manufacturing. As part of Lonza's restructured CDMO business model, the Rockland facility contributes to three integrated platforms: Integrated Biologics, Advanced Synthesis, and Specialized Modalities. This strategic positioning enables seamless collaboration across development stages while maintaining operational excellence in pharmaceutical manufacturing for global healthcare companies seeking reliable contract manufacturing partnerships.